| 1. Alencar JE. Expansão do calazar no Brasil. Ceará Médico 5:86-102, 1983.2. Al-Jurayyan AM, Al-Ayed IH, Al-Nasser NS, Al-Mugeiren MA, Boohene AG, Al-Herbish AS. Visceral leishmaniais in infancy and childhood epidemiology and clinicopathological study of 63 cases in Al-Baha Province, Saudi Arabia. Journal of Tropical Pediatrics 38:12-16, 1992.3. Badaró R, Jones TC, Lorenço R, Cerf BJ, Sampaio D, Carvalho E, Rocha H, Teixeira R, Johnson Jr WD. A prospective study of visceral lesihmaniasis in an endemic area of Brazil. The Journal of Infectious Diseases 154:639-649, 1986.4. Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. European Journal Clinical Microbiology Infectious Disease 21:277-282, 2002.5. Cole ACE. Kala-azar in East África. Transaction of the Royal Society of Tropical Medicine Hygiene 37:409, 1944.6. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG. Epi Info, version 6.02: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention. Atlanta, Georgia, USA, 1994.7. Ebrahim GJ, Sullivan KR. Tipos de Estudos - I. In: Métodos de Pesquisa em Saúde Materno Infantil. Recife, p.89-94, 1996.8. Grimaldi Jr G, Tesh R. Leishmaniasis of the New World current concepts and implications for future research. Clinical Microbiology Review 6:230-250, 1993.9. Fundação Nacional de Saúde. Guia de Doenças da Fundação Nacional de Saúde. URL: http://www.funasa.gov.br/guia_epi/htm/doencas/leishmaniose_viceral /index.htm, 1999-2000.10. Kager PA, Rees PH, Manguyu FM, Bhatt KM, Hockmeyer WT, Wellde BT, Lyerly Jr WH. Clinical presentation of visceral leishmaniasis in Kenya: a prospective study of 64 patients. Tropical and Geographical Medicine 35:323-331, 1983.11. Marwaha M, Sarode S, Gupta RK, Garewal G, Dash S. Clinico-hematological characteristics in patients with kala azar. Tropical and Geographical Medicine 43:357-362, 1991.12. Napier LE. The principles and practice of Tropical Medicine. Mac Millan Company. New York, 1946.13. Nascimento MDSB, Costa JML, Fiori BIP, Viana GMC, Filho MSG, Alvim AC, Bastos OC, Nakatani M, Reed S, Badaró R, Silva AR, Burattini MN. Aspectos epidemiológicos determinantes na manutenção da leishmaniose visceral no Estado do Maranhão Brasil. Revista da Sociedade Brasileira de Medicina Tropical 29:233-240,1996.14. Peña LFL, Yago FC, Amoros EC, Felipe PG, Fabregat RM, Tomas PE. Kala-azar infantil: casuística de una década. Anales Españoles de Pediatria, 39:199-201, 1993.15. Penna HA. Leishmaniose visceral no Brasil. Brasil Médico 46:949-950,1934.16. Prata A. Estudo clínico e laboratorial do calazar. Salvador-Ba, Livre Docência - Faculdade de Medicina da Universidade da Bahia, 1957.17. Snedecor GW, Cochran WG. Statistical Methods. Eighth edition, Iowa State University Press/Ames, 1989.18. Totan M, Dagdemir A, Muslu A, Albayrak D. Visceral childhood leishmaniasis in Turkey. Acta Paediatrica 91:62-64, 2002.19. World Health Organization. Report of the informal meeting on the chemotherapy of visceral leishmaniasis. Geneva, 1982.20. World Health Organization. The leishmaniases and leishmania/HIV co-infections. Fact Sheet Nº 116, revised May 2000.21. Zijlstra EE, Siddig AM, El-Hassan AM, El-Toum IA, Satti M, Ghalib HW. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults. Journal of Tropical Pediatrics 38:17-21, 1992. |
| Pedrosa CMS. Leishmaniose visceral em Alagoas. Revista da Sociedade Brasileira de Medicina Tropical. Brasil: v.31, p.103-105, 1998.Zwingenberger K, Pedrosa CMS, Harms G, Pessoa MC, Sandkamp B, Scheibenbogen C, Andreesen R. Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta. Immunobiology, v.183, p.125-132, 1991.Harms G, Pedrosa CMS, Zwingenberger K, Feldmeir H, Omena S. Natural killer cell activity in visceral leishmaniasis. Transactios of the Royal Society of Tropical Medicine and Hygiene. v.85, n.01, p.54-55, 1991.Zwingenberger K, Pedrosa CMS, Harms G, Omena S, Sandkamp B, Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-y production. Clinical Imunology and Immunopatology. v.57, p.242-249, 1990.Pedrosa CMS, Santos MCP. Inquérito epidemiológico com histoplasmina e paracoccdioidina em Arapiraca - Alagoasl. Revista da Sociedade Brasileira de Medicina Tropical. v.23, p.213-215, 1990.Dacal RC, Pedrosa CMS, Siqueira JGV. Calazar canino em Alagoas. Scientia ad Sapientiam. v.09, p.09-11, 1982. |
